72Spire Healthcare Annual Review 2010Spire Healthcare Limited PartnershipNotes to the financial statementsFor the year ended 31 December 201025. Financial risk management continuedSensitivity analysis A change of 25 basis points in interest rates at the reporting date would have increased/(decreased) equity and reported results by the amounts shown below. This analysis assumes that all other variables remain constant.Profit or lossEquity25 bp increase£00025 bp decrease£00025 bp increase£00025 bp decrease£000At 31 December 2010Variable rate instruments(815)815 (815)815 Interest rate swaps662 (662)15,707 (15,707)Interest rate cap66 (66)66 (66)Sensitivity (net)(87)87 14,958 (14,958)Profit or lossEquity25 bp increase£00025 bp decrease£00025 bp increase£00025 bp decrease£000At 31 December 2009Variable rate instruments(822)822 (822)822 Interest rate swap662 (662)18,202 (18,202)Interest rate collar66 (66)66 (66)Sensitivity (net)(94)94 17,446 (17,446)

73Spire Healthcare Limited Partnership26. Related party transactions Trading transactionsDuring the year, Group companies entered into the following transactions:2010£0002009£000Rozier S.ar.lInterest payable64,22257,341ManagementInterest payable336217Cinven FundsInterest payable-582Loans due to related parties2010£0002009£000Rozier S.ar.l598,816534,555Management3,0112,688Cinven Funds--Amounts payable to Rozier S.ar.l and Management carry interest of 12% (2009: 12%) per annum.Amounts payable to Cinven Funds carried interest of LIBOR plus 1.25% per annum.Other transactions with CinvenMonitoring fees totalling £0.5 million (2009: £0.5 million) were paid to Cinven Limited in respect of the monitoring of the performance of the company on behalf of the Cinven Funds. As at 31 December 2010, £0.1 million (2009: £0.1 million) was unpaid.Transactions with key management personnelThe Group made payments to key management personnel for services provided to the Group. The total remuneration to key management personnel is £2.2 million (2009: £2.8 million), which includes pension costs of £0.3 million (2009: £0.5 million).27. AcquisitionsOn 29 March 2010, the Group acquired 100% of the issued ordinary shares of London Fertility Centre Limited, a company which provides assisted conception services, for a total cash consideration of £4.5 million.On 1 July 2010 the Group acquired an orthopaedic business for a cash consideration of £1 million.On 7 October, the Group acquired 50.1% of the ordinary shares of The London Cognitive Behaviour Therapy Centres Limited for a consideration of £0.6 million.